Lv2
120 积分 2024-04-25 加入
Recurrent pulmonary thrombosis after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
4天前
已完结
Approvals by the China NMPA in 2024
10天前
已完结
Superior Benefits of Combining Mepolizumab With Sinus Surgery Compared to Mepolizumab Alone: Results From a Randomised 6‐Month Trial
14天前
已完结
Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma
22天前
已完结
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
24天前
已完结
Understanding the CRSwNP Patient as Whole
25天前
已完结
Current Review of Comorbidities in Chronic Rhinosinusitis
26天前
已完结
Sotatercept: The First FDA-Approved Activin A Receptor IIA Inhibitor Used in the Management of Pulmonary Arterial Hypertension
1个月前
已完结
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients
1个月前
已关闭
Sotatercept: A New Era in Pulmonary Arterial Hypertension
1个月前
已完结
皖公网安备34019202002308
